Union Pacific Set for Double-Digit Earnings Boom in 2026: Why Hightower’s Stephanie Link Is Betting Big Economic Tailwinds Fuel Volume Growth: A robust U.S. economy in 2026 could boost freight volumes, pushing Union Pacific’s earnings into double digits. Margin Expansion Through Efficiency: Cost savings and productivity gains are set to widen margins, adding fuel to […]
Union Pacific’s Double-Digit Earnings Bet for 2026 Read More »
US Freezes $42B Trade Pact with UK Over Digital Tax Row: A Wake-Up Call for Tech Giants and Global Trade. Key Takeaways Major Setback for UK Tech Growth: The pause on the $42B Tech Prosperity Deal halts billions in US investments, potentially delaying AI hubs and 5,000 new jobs in the UK. Digital Tax at
US Freezes $42B UK Tech Deal Over Digital Tax Read More »
Marvell (MRVL) Stock Surges After Q3 Earnings – Is It a Buy? Record Revenue Surge: Marvell smashed Q3 expectations with $2.075 billion in sales, up 37% year-over-year, driven by booming AI data center demand. Stock Jump and Pullback: Shares spiked 10% post-earnings to over $100 but have settled around $84 as of December 17, 2025
Marvell Stock Surges After Q3 Earnings Read More »
Breakthrough Alert: T-DXd/Pertuzumab Earns FDA Approval for Advanced HER2+ Breast Cancer Treatment Key Takeaways Game-Changer for Patients: The FDA’s recent approval of T-DXd (Enhertu) combined with Pertuzumab marks the first major first-line advance in over a decade for unresectable or metastatic HER2-positive breast cancer, slashing progression risk by 44%. Impressive Trial Results: In the DESTINY-Breast09
FDA Approves T-DXd + Pertuzumab for HER2+ Read More »
Is Oracle Stock (ORCL) a Buy After the Latest Earnings Shock? Oracle’s cloud business is exploding: Revenue hit $8 billion in Q2 FY2026, up 34% year-over-year, with infrastructure surging 66% – a clear sign AI demand is real. Massive backlog signals future wins: Remaining Performance Obligations (RPO) jumped 438% to $523 billion, locking in years
Oracle Stock: Buy the Dip After Q2 Shock? Read More »
‘Is This Fair?’ Mutual Funds with a Broker Earning 26% Returns But Charging 2% Fees: Is It a Worthwhile Tradeoff? Key Takeaways High fees can eat into gains: A 2% fee might seem small, but over 30 years, it could cost you tens of thousands in lost returns on even modest investments. 26% returns sound
Mutual Funds: 26% Returns but 2% Fees—Fair? Read More »
U.S. Halts UK Tech Trade Deal Negotiations: FT Reports on a Major Setback for Global Innovation Key Takeaways Sudden Pause in Talks: The U.S. has suspended the $40 billion Tech Prosperity Deal with the UK, focusing on AI and quantum tech, due to slow progress on trade barriers. Frustrations Over Rules: Key issues include the
US Halts UK Tech Deal Talks: FT Report Read More »
What to Expect in Markets This Week: Jobs Report, Inflation Data, and Earnings from Micron, Nike, and FedEx Key Takeaways Jobs Report on Deck: The November 2025 US jobs data drops Tuesday, December 16, with economists eyeing just 40,000-50,000 new jobs amid a fragile labor market, which could signal more Fed rate cuts if weak.
Markets This Week: Jobs, Inflation & Earnings Read More »
Earnings Week Ahead: FDX, NKE, MU, BB, CCL, ACN, and More – Key Insights for December 2025 Investors
Earnings Week Ahead: FDX, NKE, MU & More Read More »
Major Earnings Before the Open Monday: Spotlight on December 15, 2025 Reports and What They Mean for Investors Small but significant players dominate: While no S&P 500 giants reported, biotech and tech firms like ABVX (market cap $9.3B) showed promise with EPS surprises. Stock volatility lessons: Earnings beats led to 5-10% gains for some, but
Major Earnings Before Open: Dec 15, 2025 Read More »